Palo Alto Investors LP Novo Cure LTD Transaction History
Palo Alto Investors LP
- $501 Million
- Q1 2025
A detailed history of Palo Alto Investors LP transactions in Novo Cure LTD stock. As of the latest transaction made, Palo Alto Investors LP holds 1,002,061 shares of NVCR stock, worth $17.1 Million. This represents 3.57% of its overall portfolio holdings.
Number of Shares
1,002,061
Previous 814,191
23.07%
Holding current value
$17.1 Million
Previous $24.3 Million
26.4%
% of portfolio
3.57%
Previous 3.88%
Shares
7 transactions
Others Institutions Holding NVCR
# of Institutions
266Shares Held
79.4MCall Options Held
970KPut Options Held
118K-
Black Rock Inc. New York, NY12.1MShares$207 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$192 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.95MShares$153 Million0.03% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT5.52MShares$94.4 Million8.14% of portfolio
-
Capital World Investors Los Angeles, CA5.22MShares$89.2 Million0.02% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.79B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...